Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Filanesib + Pomalidomide + Dexamethasone in R/R MM
NCT02384083Phase 2Completed
- Sponsor
- Fundación PETHEMA
- Start
- Sep 2015
- Primary completion
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of filanesib in multiple myeloma (MM), sponsored by Fundación PETHEMA. Started Sep 2015; status: completed.
02
Drugs
filanesib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT02384083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02384083.